Core A is the molecular biology component of the Program. It will have four important functions: 1) Test all biopsies and eyebrow hair samples for the presence of beta HPV DMA. 2) Test sera for the presence of antibodies to beta HPVs. 3) Develop and maintain computerized databases that will be used to track tissue samples and mice, to generate work lists and to link histology and laboratory test results with individual mice or specimen. 4) Archive plasmids, cell lines and retroviruses. In addition this Core has a developmental component to establish a multiplex, high-throughput assay to detect HPV DMAs. For the detection or beta HPV DMAwe will be amplifying beta HPV DMA using a set of primers from a conserved region in the E1 open reading frame. The amplified DMAwill be cloned and sequenced (10 clones per sample). Blast searches will be use to identify the HPVs as known or novel HPVs. For the detection of antibodies to HPVs, we will adopt a method that has recently been established in our laboratory that has the ability to test for antibodies to numerous alpha, beta, gamma and mu HPV types simultaneously, and to do so in a highly sensitive and specific fashion. This method uses Luminex technology in which GST- LI proteins are coupled to colored polystyrene beads. The beads are mixed together, along with serum and a standard detection reagent, and the Luminex reads the amount of antibody bound to each bead. The greatest strengths of this Core are the laboratory personnel, the outside experts that have agreed to consult with us on the development and implementation of testing protocols, and the excellent facilities available at the Fred Hutchinson Cancer Center. All of Core A personnel have strong track records and extensive experience in the work required for this Core.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Program Projects (P01)
Project #
5P01CA042792-22
Application #
8118871
Study Section
Special Emphasis Panel (ZCA1)
Project Start
Project End
Budget Start
2010-07-01
Budget End
2011-06-30
Support Year
22
Fiscal Year
2010
Total Cost
$367,073
Indirect Cost
Name
Fred Hutchinson Cancer Research Center
Department
Type
DUNS #
078200995
City
Seattle
State
WA
Country
United States
Zip Code
98109
Bao, Xiao; Hanson, Aimee L; Madeleine, Margaret M et al. (2018) HLA and KIR Associations of Cervical Neoplasia. J Infect Dis 218:2006-2015
Leo, Paul J; Madeleine, Margaret M; Wang, Sophia et al. (2017) Defining the genetic susceptibility to cervical neoplasia-A genome-wide association study. PLoS Genet 13:e1006866
Wallace, Nicholas A; Khanal, Sujita; Robinson, Kristin L et al. (2017) High-Risk Alphapapillomavirus Oncogenes Impair the Homologous Recombination Pathway. J Virol 91:
Madeleine, Margaret M; Johnson, Lisa G; Doody, David R et al. (2016) Natural Antibodies to Human Papillomavirus 16 and Recurrence of Vulvar High-Grade Intraepithelial Neoplasia (VIN3). J Low Genit Tract Dis 20:257-60
Hardikar, Sheetal; Johnson, Lisa G; Malkki, Mari et al. (2015) A population-based case-control study of genetic variation in cytokine genes associated with risk of cervical and vulvar cancers. Gynecol Oncol 139:90-6
Wallace, Nicholas A; Robinson, Kristin; Howie, Heather L et al. (2015) ?-HPV 5 and 8 E6 disrupt homology dependent double strand break repair by attenuating BRCA1 and BRCA2 expression and foci formation. PLoS Pathog 11:e1004687
Galloway, Denise A; Laimins, Laimonis A (2015) Human papillomaviruses: shared and distinct pathways for pathogenesis. Curr Opin Virol 14:87-92
Safaeian, Mahboobeh; Johnson, Lisa G; Yu, Kai et al. (2014) Human Leukocyte Antigen Class I and II Alleles and Cervical Adenocarcinoma. Front Oncol 4:119
Madeleine, Margaret M; Carter, Joseph J; Johnson, Lisa G et al. (2014) Risk of squamous cell skin cancer after organ transplant associated with antibodies to cutaneous papillomaviruses, polyomaviruses, and TMC6/8 (EVER1/2) variants. Cancer Med 3:1440-7
Wallace, Nicholas A; Galloway, Denise A (2014) Manipulation of cellular DNA damage repair machinery facilitates propagation of human papillomaviruses. Semin Cancer Biol 26:30-42

Showing the most recent 10 out of 127 publications